Assay & Detection

SARS-CoV-2 IgG ELISA

NEW
SARS-CoV-2 IgG ELISA Kit (For Research Use Only)

Article No

E88-301

Species Reactivity

human

Size

1 x 96 wells

Documentation

Specifications

Additional Information Coronavirus Disease 2019 (COVID-19) is a systemic disease caused by the novel Coronavirus designated SARS-CoV-2. The initial disease outbreak was first reported in Wuhan, Hubei province, China in December 2019. Within months the World Health Organization declared a global pandemic. COVID-19 can be a serious and life-threatening disease. “Understanding the number of individuals who are exposed and whether they then develop immunity is absolutely key to managing the epidemic.” (Ragon Institute of MGH, MIT and Harvard, n.d.)
Article No E88-301
Country Availability SE, FI, DK, NO, IS, EE, LV, LT, RU
Description SARS-CoV-2 IgG ELISA Kit (For Research Use Only)
Supplier Bethyl Laboratories
Notes The Bethyl SARS-CoV-2 IgG ELISA is an Enzyme-Linked Immunosorbent Assay (ELISA) intended for semiquantitative detection of IgG antibodies to SARS-CoV-2 in human serum or plasma collected in Potassium EDTA, Sodium Citrate or Lithium Heparin. The Bethyl SARS-CoV-2 IgG ELISA is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. Understanding the timing, duration and effectiveness of humoral immune responses in individuals previously infected with SARS-CoV-2 will be important for conducting vaccine and epidemiological research. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity. Results are for the detection of SARS-CoV-2 antibodies. IgG antibodies to SARS-CoV-2 are generally detectable in blood several days after initial infection, although the duration of time antibodies are present post-infection is not well characterized. Individuals may have detectable virus present for several weeks following seroconversion.
Alias Names covid-19, 2019-nCoV
Product Type Assay & Detection
Research Area Virology, Inflammation
Sensitivity The sensitivity of Bethyl SARS-CoV-2 IgG ELISA early after infection is unknown. Negative results do not preclude acute SARS-CoV-2 infection. False positive results for Bethyl SARS-CoV-2 IgG ELISA may occur due to cross-reactivity from pre-existing antibodies to SARS-CoV-1 or other possible causes.
Size 1 x 96 wells
Species Reactivity human
Storage 4°C
Product Page Updated 2021-02-18T14:35:21.228Z

Shipping info

The delivery time for this item is approximately 5-8 business days. 
If other deviations occur, this will be noted on the order confirmation or communicated via email.
Please note, we do reserve the right to select the best packaging and shipping method in order to insure the stability of the product and allow efficient order tracking.